The Cost-Effectiveness of a Telaprevir-Inclusive Regimen as Initial Therapy for Genotype 1 Hepatitis C Infection in Individuals with the Cc Il-28B Polymorphism

Gellad, Ziad F., Naggie, Susanna, Reed, Shelby D., Clark, Paul J., Thompson, Alex J., Schulman, Kevin A. and Muir, Andrew J. (2011). The Cost-Effectiveness of a Telaprevir-Inclusive Regimen as Initial Therapy for Genotype 1 Hepatitis C Infection in Individuals with the Cc Il-28B Polymorphism. In: Hepatology. 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San Francisco Ca, (417A-418A). Nov 04-08, 2011.

Author Gellad, Ziad F.
Naggie, Susanna
Reed, Shelby D.
Clark, Paul J.
Thompson, Alex J.
Schulman, Kevin A.
Muir, Andrew J.
Title of paper The Cost-Effectiveness of a Telaprevir-Inclusive Regimen as Initial Therapy for Genotype 1 Hepatitis C Infection in Individuals with the Cc Il-28B Polymorphism
Conference name 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)
Conference location San Francisco Ca
Conference dates Nov 04-08, 2011
Proceedings title Hepatology   Check publisher's open access policy
Publication Year 2011
Sub-type Published abstract
Open Access Status
ISSN 0270-9139
Volume 54
Start page 417A
End page 418A
Total pages 2
Language eng
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Conference Paper
Collection: ResearcherID Downloads
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 11 times in Thomson Reuters Web of Science Article | Citations
Google Scholar Search Google Scholar
Created: Tue, 16 Sep 2014, 13:04:30 EST by Ms Kate Rowe on behalf of Scholarly Communication and Digitisation Service